A Study in Recurrent Glioblastoma (GB)
Clinical trial NCT01582269 · COMPLETED
Trial details
- NCT number
- NCT01582269
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-26
- Primary completion
- 2014-07-26
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.